Response Biomedical Corp (OTCBB - OTCQB:RPBIF.OB)
| 3.75 Data as of May 20 |  0.00 / 0.00%Today’s Change | 0.95 Today|||52-Week Range 5.57 | +251.26% Year-to-Date |
Latest RPBIF.OB News | Press Releases
No recent news for Response Biomedical Corp.
Today’s Trading
| Previous close | 3.75 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 911 |
| Market cap | $24.7M |
| Dividend yield | -- |
Data as of 05/20/2013
Growth & Valuation
| Earnings growth (last year) | +71.01% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +22.76% |
| P/E ratio | -- |
| Price/Sales | 0.61 |
| Price/Book | 75.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GOGCGlobal Green Inc | +0.00 | +10.00% |
| VRNMVerenium Corp | -0.09 | -4.02% |
| BPAXBioSante Pharmaceuti... | 0.00 | 0.00% |
| KDUSCadus Corp | -0.01 | -0.73% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $11.8M |
| Annual profit (last year) | -$5.3M |
| Net profit margin | -44.94% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Jeffrey L. Purvin, MBA |
Chief Financial Officer & Secretary Bill J. Adams, CFA, MBA |
Corporate headquarters Vancouver, British Columbia |
Forecasts
